TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
761,417
|
1,571,168
|
732,832 |
| Earnings before taxes |
43,846
|
35,780
|
22,308 |
| Total assets |
357,642
|
779,352
|
354,474 |
| Current assets |
341,909
|
375,525
|
354,254 |
| Current liabilities |
216,480
|
217,807
|
208,001 |
| Equity capital |
139,583
|
489,141
|
143,487 |
| - share capital |
4,000
|
4,000
|
4,000 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.0%
|
62.8%
|
40.5% |
| Turnover per employee |
5,076
|
10,474
|
4,886 |
| Profit as a percentage of turnover |
5.8%
|
2.3%
|
3.0% |
| Return on assets (ROA) | |||
| Current ratio |
157.9%
|
172.4%
|
170.3% |
| Return on equity (ROE) |
31.4%
|
7.3%
|
15.5% |
| Change turnover |
-809,751
|
838,336
|
30,982 |
| Change turnover % |
-52%
|
114%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.